Literature DB >> 18760322

Nephrotoxicity caused by brown spider venom phospholipase-D (dermonecrotic toxin) depends on catalytic activity.

J Kusma1, O M Chaim, A C M Wille, V P Ferrer, Y B Sade, L Donatti, W Gremski, O C Mangili, S S Veiga.   

Abstract

Bites from brown spiders (Loxosceles genus) have clinical manifestations including skin necrosis with gravitational spreading, and systemic involvement that may include renal failure, hemolysis, and thrombocytopenia. Mice were exposed to recombinant wild-type phospholipase-D, or to an isoform with a mutation in the catalytic domain resulting in no phospholipasic activity. Renal biopsies from mice treated with the wild-type toxin showed glomerular edema, erythrocytes and collapse of Bowman's space, edema and deposition of proteinaceous material within the tubular lumen. Ultrastructural analyses confirmed cytotoxicity by demonstrating disorders of glomerulus at foot processes and at fenestrated endothelium. Tubule alterations include deposits of amorphous material and edema, as well as an increase of epithelial cytoplasmic multivesicular bodies and electron-dense structures. There was an absence of nephrotoxicity in mice treated with the mutated toxin. Analyses of urine and blood showed that wild type toxin induced hematuria and elevation of blood urea, while treatment with mutated toxin caused no changes. Mouse lethality experiments also showed oliguria and mortality after treatment with wild-type toxin, but not following exposure to the mutated toxin. Immunofluorescence using antibodies to phospholipase-D toxin showed deposition of both toxins along the renal tubular structures as detected by confocal microscopy. Immunoblots of urine showed a 30 kDa band in samples from animals treated with wild-type toxin, but no band from mice exposed to mutated toxin. Wild-type toxin treatment caused cytoplasmic vacuolization, impaired spreading, reduction of cellular viability, and cell-cell and cell-substratum detachment in MDCK cells, while treatment with mutated isoform had no effect. Finally, there is a direct correlation between toxin activity on cell membrane phospholipids generating choline and cytotoxicity. We have defined for the first time a molecular mechanism for Loxosceles venom nephrotoxicity that is dependent on the catalytic activity of phospholipase-D toxin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18760322     DOI: 10.1016/j.biochi.2008.07.011

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  14 in total

1.  Shear stress induces cell apoptosis via a c-Src-phospholipase D-mTOR signaling pathway in cultured podocytes.

Authors:  Chunfa Huang; Leslie A Bruggeman; Lindsey M Hydo; R Tyler Miller
Journal:  Exp Cell Res       Date:  2012-03-26       Impact factor: 3.905

2.  Crystallization and preliminary X-ray diffraction analysis of a class II phospholipase D from Loxosceles intermedia venom.

Authors:  Anwar Ullah; Priscila Oliveira de Giuseppe; Mario Tyago Murakami; Dilza Trevisan-Silva; Ana Carolina Martins Wille; Daniele Chaves-Moreira; Luiza Helena Gremski; Rafael Bertoni da Silveira; Andrea Sennf-Ribeiro; Olga Meiri Chaim; Silvio Sanches Veiga; Raghuvir Krishnaswamy Arni
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-01-22

3.  Variable Substrate Preference among Phospholipase D Toxins from Sicariid Spiders.

Authors:  Daniel M Lajoie; Sue A Roberts; Pamela A Zobel-Thropp; Jared L Delahaye; Vahe Bandarian; Greta J Binford; Matthew H J Cordes
Journal:  J Biol Chem       Date:  2015-03-09       Impact factor: 5.157

4.  A novel hyaluronidase from brown spider (Loxosceles intermedia) venom (Dietrich's Hyaluronidase): from cloning to functional characterization.

Authors:  Valéria Pereira Ferrer; Thiago Lopes de Mari; Luiza Helena Gremski; Dilza Trevisan Silva; Rafael Bertoni da Silveira; Waldemiro Gremski; Olga Meiri Chaim; Andrea Senff-Ribeiro; Helena Bonciani Nader; Silvio Sanches Veiga
Journal:  PLoS Negl Trop Dis       Date:  2013-05-02

Review 5.  Brown spider (Loxosceles genus) venom toxins: tools for biological purposes.

Authors:  Olga Meiri Chaim; Dilza Trevisan-Silva; Daniele Chaves-Moreira; Ana Carolina M Wille; Valéria Pereira Ferrer; Fernando Hitomi Matsubara; Oldemir Carlos Mangili; Rafael Bertoni da Silveira; Luiza Helena Gremski; Waldemiro Gremski; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2011-03-22       Impact factor: 4.546

Review 6.  Highlights in the knowledge of brown spider toxins.

Authors:  Daniele Chaves-Moreira; Andrea Senff-Ribeiro; Ana Carolina Martins Wille; Luiza Helena Gremski; Olga Meiri Chaim; Silvio Sanches Veiga
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-02-08

7.  Recombinant Phospholipase D from Loxosceles gaucho Binds to Platelets and Promotes Phosphatidylserine Exposure.

Authors:  Daniel A Fukuda; Maria C Caporrino; Katia C Barbaro; Maisa S Della-Casa; Eliana L Faquim-Mauro; Geraldo S Magalhaes
Journal:  Toxins (Basel)       Date:  2017-06-13       Impact factor: 4.546

8.  Tetracycline Reduces Kidney Damage Induced by Loxosceles Spider Venom.

Authors:  Cinthya Kimori Okamoto; Carmen W van den Berg; Mizuno Masashi; Rute M Gonçalves-de-Andrade; Denise V Tambourgi
Journal:  Toxins (Basel)       Date:  2017-03-02       Impact factor: 4.546

Review 9.  Prospective Use of Brown Spider Venom Toxins as Therapeutic and Biotechnological Inputs.

Authors:  Luiza Helena Gremski; Fernando Hitomi Matsubara; Nayanne Louise Costacurta Polli; Bruno Cesar Antunes; Pedro Henrique de Caires Schluga; Hanna Câmara da Justa; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Front Mol Biosci       Date:  2021-06-17

10.  Identification of new sphingomyelinases D in pathogenic fungi and other pathogenic organisms.

Authors:  Camila Dias-Lopes; Izabella A P Neshich; Goran Neshich; José Miguel Ortega; Claude Granier; Carlos Chávez-Olortegui; Franck Molina; Liza Felicori
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.